Skip to main content
H.R. 2376 116th Congress House

Prescription Pricing for the People Act of 2019

Official title: To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.

Introduced: May 1, 2019 See on congress.gov
Commerce Business ethicsBusiness recordsCompetition and antitrustCongressional oversight
More subjectsShow fewer subjects
Consumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale trades
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 7 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 21, 2019
Subcommittee Hearings Held.
Apr 30, 2019
Referred to the Subcommittee on Consumer Protection and Commerce.
Apr 30, 2019
Ordered to be Reported by Voice Vote.
Apr 30, 2019
Committee Consideration and Mark-up Session Held.
Apr 30, 2019
Referred to the Subcommittee on Health.
Apr 29, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 29, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 21, 2019

Subcommittee Hearings Held.

 Plain-English summary Congressional Research Service

Prescription Pricing for the People Act of 2019

This bill directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain.

 Related & companion bills 3
  • HR 19 Lower Costs, More Cures Act of 2019
  • S 1227 Prescription Pricing for the People Act of 2019
  • HR 2296 More Efficient Tools to Realize Information for Consumers Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 7
All 7 Democratic 4
D
Pocan, Mark
Wisconsin · Sep 18, 2019
Porter, Katie
· Jul 10, 2019
 D
Neguse, Joe
Colorado · May 7, 2019
Rose, Max
· May 7, 2019
 D
Cohen, Steve
Tennessee · May 1, 2019
Meadows, Mark
· May 1, 2019
 D
Nadler, Jerrold
New York · Apr 29, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2376: Prescription Pricing for the People Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-2376/
MLA
"H.R. 2376: Prescription Pricing for the People Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-2376/.
Bluebook (legal)
H.R. 2376, 116th Cong. (2026), https://openamerica.io/bill/116-HR-2376/.
Markdown link
[H.R. 2376: Prescription Pricing for the People Act of 2019](https://openamerica.io/bill/116-HR-2376/)
Report a problem